[PHARMA] YoY Quarter Result on 30-Sep-2012 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
06-Nov-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Sep-2012 [#3]
Profit Trend
QoQ- 60.68%
YoY- 133.53%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 524,413 502,086 440,807 426,460 371,432 334,337 329,962 8.02%
PBT 25,337 24,945 13,461 28,493 15,646 15,405 9,427 17.90%
Tax -5,362 -9,944 -9,291 -2,957 -4,687 -6,970 -3,032 9.96%
NP 19,975 15,001 4,170 25,536 10,959 8,435 6,395 20.89%
-
NP to SH 19,971 14,955 3,751 25,247 10,811 8,586 6,059 21.98%
-
Tax Rate 21.16% 39.86% 69.02% 10.38% 29.96% 45.25% 32.16% -
Total Cost 504,438 487,085 436,637 400,924 360,473 325,902 323,567 7.67%
-
Net Worth 534,373 507,124 473,402 496,469 464,092 424,488 407,858 4.60%
Dividend
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Div 23,312 20,698 7,760 11,764 - - 28,903 -3.51%
Div Payout % 116.73% 138.41% 206.90% 46.60% - - 477.03% -
Equity
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Net Worth 534,373 507,124 473,402 496,469 464,092 424,488 407,858 4.60%
NOSH 259,027 258,737 258,689 117,646 106,933 106,924 107,049 15.85%
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin 3.81% 2.99% 0.95% 5.99% 2.95% 2.52% 1.94% -
ROE 3.74% 2.95% 0.79% 5.09% 2.33% 2.02% 1.49% -
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
RPS 202.45 194.05 170.40 362.49 347.35 312.69 308.23 -6.76%
EPS 7.71 5.78 1.45 21.46 10.11 8.03 5.66 5.28%
DPS 9.00 8.00 3.00 10.00 0.00 0.00 27.00 -16.72%
NAPS 2.063 1.96 1.83 4.22 4.34 3.97 3.81 -9.71%
Adjusted Per Share Value based on latest NOSH - 117,646
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
RPS 36.39 34.84 30.59 29.59 25.77 23.20 22.89 8.02%
EPS 1.39 1.04 0.26 1.75 0.75 0.60 0.42 22.06%
DPS 1.62 1.44 0.54 0.82 0.00 0.00 2.01 -3.52%
NAPS 0.3708 0.3519 0.3285 0.3445 0.322 0.2945 0.283 4.60%
Price Multiplier on Financial Quarter End Date
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Date 30/09/15 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 30/09/09 -
Price 6.50 4.63 4.82 7.55 5.90 4.98 4.09 -
P/RPS 3.21 2.39 2.83 2.08 1.70 1.59 1.33 15.81%
P/EPS 84.31 80.10 332.41 35.18 58.36 62.02 72.26 2.60%
EY 1.19 1.25 0.30 2.84 1.71 1.61 1.38 -2.43%
DY 1.38 1.73 0.62 1.32 0.00 0.00 6.60 -22.94%
P/NAPS 3.15 2.36 2.63 1.79 1.36 1.25 1.07 19.70%
Price Multiplier on Announcement Date
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Date 26/11/15 21/11/14 19/11/13 06/11/12 01/11/11 04/11/10 13/11/09 -
Price 6.50 4.45 4.72 8.25 5.90 4.92 3.93 -
P/RPS 3.21 2.29 2.77 2.28 1.70 1.57 1.28 16.55%
P/EPS 84.31 76.99 325.52 38.44 58.36 61.27 69.43 3.28%
EY 1.19 1.30 0.31 2.60 1.71 1.63 1.44 -3.12%
DY 1.38 1.80 0.64 1.21 0.00 0.00 6.87 -23.46%
P/NAPS 3.15 2.27 2.58 1.95 1.36 1.24 1.03 20.46%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment